Literature DB >> 7504304

Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.

M S Sandrin1, H A Vaughan, P L Dabkowski, I F McKenzie.   

Abstract

A major problem with pig-to-human-tissue xenograft studies is that humans have natural antibodies to pig cells; these antibodies would cause hyperacute rejection if pig tissues were xenografted to humans. Here we show that most of human IgM antibodies present in the serum of healthy donors and reactive with pig cells react with galactose in an (alpha 1-3) linkage with galactose--i.e., Gal(alpha 1-3)Gal. Absorption studies demonstrated that the antibodies detected the same or similar epitopes on the surface of pig erythrocytes, blood and splenic lymphocytes, and aortic endothelial cells (EC). The antibodies were sensitive to 2-mercaptoethanol (2ME) treatment, did not bind to protein A or G, and were present in the high molecular weight fraction of serum; they are clearly IgM antibodies. Further, the antibodies did not react with human ABO blood group substances and are not related to human blood group A or B, which carry a terminal galactose. The reaction of human serum with pig erythrocytes was specifically inhibited by mono- and disaccharides: D-galactose, melibiose, stachyose, methyl-alpha-D-galactopyranoside, and D-galactosamine but not by D-glucose or methyl-beta-D-galactopyranoside; demonstrating that the reaction is with galactose in an alpha and not a beta linkage. A cDNA clone encoding the murine alpha-1,3-galactosyltransferase (which transfers a terminal galactose residue with an (alpha 1-3) linkage to a subterminal galactose) was isolated by polymerase chain reaction (PCR), cloned, and transfected into COS cells, which are of Old World monkey origin and, like humans, do not express Gal(alpha 1-3)Gal. After transfection, COS cells became strongly reactive with human serum and with IB4 lectin [which reacts only with Gal(alpha 1-3)Gal]; this reactivity could be removed by absorption with pig erythrocytes. As most of the antibody reacting with pig cells can be removed by absorption with either melibiose or Gal(alpha 1-3)Gal+ COS cells, most of these react with Gal(alpha 1-3)Gal. These findings provide the basis for genetic manipulation of the pig alpha-1,3-galactosyltransferase for future transplantation studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504304      PMCID: PMC47988          DOI: 10.1073/pnas.90.23.11391

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  The isolation of cDNA clones for CD48.

Authors:  H A Vaughan; M M Henning; D F Purcell; I F McKenzie; M S Sandrin
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 2.  Xenogeneic transplantation. A review.

Authors:  H Auchincloss
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

3.  An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2.

Authors:  B Seed
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

4.  Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.

Authors:  D K Cooper; A H Good; Y Ye; E Koren; R Oriol; R M Ippolito; A J Malcolm; F A Neethling; E Romano; N Zuhdi
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  Hu Ly-M3--a human leukocyte antigen.

Authors:  H A Vaughan; C H Thompson; R L Sparrow; I F McKenzie
Journal:  Transplantation       Date:  1983-10       Impact factor: 4.939

6.  A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera.

Authors:  C R Parish; I F McKenzie
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

7.  Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates.

Authors:  U Galili; M R Clark; S B Shohet; J Buehler; B A Macher
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  A unique natural human IgG antibody with anti-alpha-galactosyl specificity.

Authors:  U Galili; E A Rachmilewitz; A Peleg; I Flechner
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

9.  The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies.

Authors:  U Galili; J Buehler; S B Shohet; B A Macher
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

10.  Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues.

Authors:  U Galili; B A Macher; J Buehler; S B Shohet
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  77 in total

1.  Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues.

Authors:  P B Yu; W Parker; M L Everett; I J Fox; J L Platt
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

Review 2.  Xenotransplantation: where are we today?

Authors:  M D Dooldeniya; A N Warrens
Journal:  J R Soc Med       Date:  2003-03       Impact factor: 5.344

3.  Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase.

Authors:  A Sharma; J Okabe; P Birch; S B McClellan; M J Martin; J L Platt; J S Logan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Profiling terminal N-acetyllactosamines of glycans on mammalian cells by an immuno-enzymatic assay.

Authors:  Haruko Ogawa; Uri Galili
Journal:  Glycoconj J       Date:  2006-11-18       Impact factor: 2.916

5.  Early Detection of Circulating Antigen and IgM-Associated Immune Complexes during Experimental Mycobacterium bovis Infection in Cattle.

Authors:  Konstantin P Lyashchenko; Rena Greenwald; Alina Sikar-Gang; Archana A Sridhara; Ashley Johnathan; Paul Lambotte; Javan Esfandiari; Mayara F Maggioli; Tyler C Thacker; Mitchell V Palmer; W Ray Waters
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

6.  Xenotransplantation as a model of integrated, multidisciplinary research.

Authors:  Emanuele Cozzi; Erika Bosio; Michela Seveso; Domenico Rubello; Ermanno Ancona
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

7.  Expeditious chemoenzymatic synthesis of homogeneous N-glycoproteins carrying defined oligosaccharide ligands.

Authors:  Hirofumi Ochiai; Wei Huang; Lai-Xi Wang
Journal:  J Am Chem Soc       Date:  2008-09-20       Impact factor: 15.419

8.  Porcine alpha-1,3-galactosyltransferase: full length cDNA cloning, genomic organization, and analysis of splicing variants.

Authors:  A Katayama; H Ogawa; K Kadomatsu; N Kurosawa; T Kobayashi; N Kaneda; K Uchimura; I Yokoyama; T Muramatsu; H Takagi
Journal:  Glycoconj J       Date:  1998-06       Impact factor: 2.916

Review 9.  Mapping the mouse genome: current status and future prospects.

Authors:  W F Dietrich; N G Copeland; D J Gilbert; J C Miller; N A Jenkins; E S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Identification of the V genes encoding xenoantibodies in non-immunosuppressed rhesus monkeys.

Authors:  Annette Kleihauer; Clare R Gregory; Dominic C Borie; Andrew E Kyles; Irina Shulkin; Insiyyah Patanwala; Joanne Zahorsky-Reeves; Vaughn A Starnes; Yoko Mullen; Ivan T Todorov; Mary Kearns-Jonker
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.